Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
GNOV: Taking a Closer Look at the FT Vest U.S. Equity Moderate Buffer ETF – November

GNOV: Taking a Closer Look at the FT Vest U.S. Equity Moderate Buffer ETF – November

Key Takeaways

  • GNOV is an actively managed "defined outcome" ETF issued by First Trust through its FT Vest lineup, launched on November 17, 2023.
  • The fund seeks to match the price return of the SPY SPDR S&P 500 ETF Trust up to a preset cap, while buffering the first 15% of SPY losses over each annual outcome period.
  • It is built primarily with FLEX Options (customized exchange-traded options) rather than holding the underlying stocks directly.
  • GNOV carries a net expense ratio of 0.85% and is classified as non-diversified.
  • The ETF is designed for investors seeking large-cap U.S. equity exposure with a degree of built-in downside protection in exchange for capped upside.

Understanding the Fund’s Structure

The FT Vest U.S. Equity Moderate Buffer ETF – November (GNOV) provides a structured approach to U.S. large-cap equities that limits losses over a set period. Part of First Trust’s FT Vest Target Outcome suite, it appeals to those who want equity market participation but prefer to avoid the full impact of sharp declines. Rather than owning shares outright, GNOV relies on options to define a specific range of outcomes, setting it apart in the ETF space. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the category.

The Fund’s Core Profile and Strategy

GNOV is an actively managed ETF from First Trust, run through the FT Vest platform that focuses on buffered and defined-outcome strategies. It launched on November 17, 2023. Instead of tracking an index by holding stocks, the fund invests primarily in FLexible EXchange (FLEX) Options tied to the price performance of the SPDR S&P 500 ETF Trust (SPY).

Its approach centers on a buffer strategy. Over each one-year outcome period, GNOV aims to deliver the price return of SPY up to a set upside cap while shielding against the first 15% of SPY losses, before fees and expenses. One recent period, for instance, featured a 13.25% cap paired with the 15% buffer. Gains above the cap are limited, while moderate losses receive protection; anything beyond the buffer falls to the investor. Because the strategy uses options and short-term collateral rather than direct holdings, the portfolio looks quite different from a standard equity ETF, with FLEX Options on SPY making up the bulk and the rest in cash or equivalents like government money-market funds. The fund is non-diversified and carries a 0.85% net expense ratio.

Why This ETF Draws Investor Interest

GNOV stands out for investors who want a defined risk-reward profile in U.S. equities. The main draw is the downside buffer that cushions the first 15% of SPY losses, offering protection not found in plain index funds. This feature can matter for risk-conscious investors, retirees, or anyone aiming to remain invested amid volatility without taking the full hit of a downturn. The ETF also delivers clear large-cap U.S. equity exposure via the S&P 500, with the cap and buffer reset each year so investors can weigh the trade-off upfront. Its structure suits roles focused on capital preservation or a more measured core equity allocation.

Important Risks and Considerations

Several factors deserve attention before considering GNOV. The upside cap prevents the fund from capturing full gains in a strong rally, so it can lag a standard S&P 500 ETF during bull markets. The 15% buffer covers only the initial portion of losses over the full outcome period, not day to day, meaning mid-period purchases or sales can produce different results than those set at launch. Its 0.85% expense ratio exceeds many plain index funds due to the options strategy. As a non-diversified fund, it carries concentration risk, and FLEX Options bring counterparty, liquidity, and pricing considerations. These elements make GNOV more complex than a typical broad-market ETF and better suited to investors comfortable with defined-outcome mechanics.

Integrating AI Tools Into My Research Process

When evaluating options-based ETFs like this one, I often turn to Tickeron’s AI Screener to quickly filter for comparable strategies and assess how they align with broader market conditions. The platform’s technical and pattern-based filters help surface ideas efficiently without replacing deeper due diligence on the specific mechanics at play.

Conclusion

The FT Vest U.S. Equity Moderate Buffer ETF – November (GNOV) offers a structured, options-driven way to gain large-cap U.S. equity exposure. By combining an upside cap with a partial downside buffer, it delivers a form of risk management absent from conventional index funds, which can suit investors focused on capital preservation alongside equity participation. Its defined-outcome design warrants consideration for those who grasp the inherent trade-offs and accept capped returns in return for moderated downside risk.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GNOV

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


GNOV in downward trend: price dove below 50-day moving average on November 16, 2026

GNOV moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 8 of 13 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 62%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for GNOV moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 7 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 20%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 12 of 43 cases where GNOV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 28%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GNOV as a result. In 20 of 43 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.

The Moving Average Convergence Divergence Histogram (MACD) for GNOV turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 30 similar instances when the indicator turned negative. In 11 of the 30 cases the stock turned lower in the days that followed. This puts the odds of success at 37%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 35%.

Bullish Trend Analysis

Following a +1.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where GNOV advanced for three days, in 175 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

GNOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 220 of 310 cases where GNOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Industry description

The investment seeks to provide investors with returns (before fees and expenses) that match the price return of the SPDR® S&P 500® ETF Trust. Under normal market conditions, the fund will invest substantially all of its assets in FLexible EXchange® Options that reference the price performance of the SPDR® S&P 500® ETF Trust. FLEX Options are customized equity or index option contracts that trade on an exchange but provide investors with the ability to customize key contract terms like exercise prices, styles and expiration dates. The fund is non-diversified.
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.